I know Donna and Paul didn’t call the results “Stellar” but they did call them “particularly unique, strong signals for disease modification, remarkable findings - particularly at 6months, no previous study out there that has shown improvement in cartilage like PAR has, world first, ground breakin”
”no other drug where a subject is dosed and 6months later, the effect of the drug is still significant. Long term, durable effect from the symptoms of OA”
yum
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-318
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.23M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.0¢ | $76.34K | 322.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3168 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 56918 | 2 |
View Market Depth
| Last trade - 11.44am 14/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |